These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 10147539)

  • 1. A critical appraisal of the cardiac arrhythmia suppression trial (CAST).
    Naccarelli GV; Dougherty AH; Wolbrette D; Wiggins S
    Appl Cardiopulm Pathophysiol; 1991; 4(1):9-16. PubMed ID: 10147539
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [What is the latest in anti-arrhythmia therapy?].
    Gloor HO
    Schweiz Med Wochenschr; 1991 Nov; 121(47):1711-4. PubMed ID: 1720259
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Cardiac Arrhythmia Suppression Trial: Implications for nursing practice.
    Kellen JC; Ettinger A; Todd L; Brezsnyak ML; Campion J; McBride R; Thomas S; Corum J; Schron E
    Am J Crit Care; 1996 Jan; 5(1):19-25. PubMed ID: 8680488
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction of baseline characteristics with the hazard of encainide, flecainide, and moricizine therapy in patients with myocardial infarction. A possible explanation for increased mortality in the Cardiac Arrhythmia Suppression Trial (CAST).
    Anderson JL; Platia EV; Hallstrom A; Henthorn RW; Buckingham TA; Carlson MD; Carson PE
    Circulation; 1994 Dec; 90(6):2843-52. PubMed ID: 7994829
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [New aspects of the clinical use of anti-arrhythmia agents with special reference to acute therapy of ventricular tachycardia (lidocaine vs. ajmaline)].
    Manz M; Mletzko R; Jung W; Lüderitz B
    Herz; 1990 Apr; 15(2):79-89. PubMed ID: 2188894
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Can sudden cardiac death be prevented by treatment with anti-arrhythmia drugs?].
    Zrenner B; Koller B; Rudolph W
    Herz; 1990 Apr; 15(2):90-102. PubMed ID: 2188895
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mortality following ventricular arrhythmia suppression by encainide, flecainide, and moricizine after myocardial infarction. The original design concept of the Cardiac Arrhythmia Suppression Trial (CAST).
    Epstein AE; Hallstrom AP; Rogers WJ; Liebson PR; Seals AA; Anderson JL; Cohen JD; Capone RJ; Wyse DG
    JAMA; 1993 Nov; 270(20):2451-5. PubMed ID: 8230622
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Events in the Cardiac Arrhythmia Suppression Trial (CAST): mortality in the entire population enrolled.
    Epstein AE; Bigger JT; Wyse DG; Romhilt DW; Reynolds-Haertle RA; Hallstrom AP
    J Am Coll Cardiol; 1991 Jul; 18(1):14-9. PubMed ID: 1904891
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circadian pattern of arrhythmic death in patients receiving encainide, flecainide or moricizine in the Cardiac Arrhythmia Suppression Trial (CAST).
    Peters RW; Mitchell LB; Brooks MM; Echt DS; Barker AH; Capone R; Liebson PR; Greene HL
    J Am Coll Cardiol; 1994 Feb; 23(2):283-9. PubMed ID: 8294678
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Implications of the Cardiac Arrhythmia Suppression Trial for antiarrhythmic drug treatment.
    Bigger JT
    Am J Cardiol; 1990 Feb; 65(8):3D-10D; discussion 68D-71D. PubMed ID: 2106253
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preliminary report: effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction.
    Cardiac Arrhythmia Suppression Trial (CAST) Investigators
    N Engl J Med; 1989 Aug; 321(6):406-12. PubMed ID: 2473403
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Cardiac Arrhythmia Suppression Trial: first CAST ... then CAST-II.
    Greene HL; Roden DM; Katz RJ; Woosley RL; Salerno DM; Henthorn RW
    J Am Coll Cardiol; 1992 Apr; 19(5):894-8. PubMed ID: 1552108
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of ventricular arrhythmias after CAST.
    Tonkin AM
    Med J Aust; 1992 Apr; 156(7):488-92. PubMed ID: 1372950
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of encainide, flecainide, imipramine and moricizine on ventricular arrhythmias during the year after acute myocardial infarction: the CAPS.
    Cardiac Arrhythmia Pilot Study (CAPS) Investigators
    Am J Cardiol; 1988 Mar; 61(8):501-9. PubMed ID: 2894169
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CAST and beyond. Implications of the cardiac arrhythmia suppression trials. By the Task Force of the Working Group on Arrhythmias of the European Society of Cardiology.
    Eur Heart J; 1990 Mar; 11(3):194-9. PubMed ID: 2108031
    [No Abstract]   [Full Text] [Related]  

  • 16. [Antiarrhythmic agents: current situation].
    Bonhorst D
    Rev Port Cardiol; 1995 May; 14(5):421-9, 362. PubMed ID: 7654403
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between ease of suppression of ventricular arrhythmia and survival.
    Goldstein S; Brooks MM; Ledingham R; Kennedy HL; Epstein AE; Pawitan Y; Bigger JT
    Circulation; 1995 Jan; 91(1):79-83. PubMed ID: 7805221
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predicting mortality after myocardial infarction from the response of RR variability to antiarrhythmic drug therapy.
    Bigger JT; Rolnitzky LM; Steinman RC; Fleiss JL
    J Am Coll Cardiol; 1994 Mar; 23(3):733-40. PubMed ID: 7509355
    [TBL] [Abstract][Full Text] [Related]  

  • 19. What have clinical trials taught us about proarrhythmia?
    Skanes AC; Green MS
    Can J Cardiol; 1996 Apr; 12 Suppl B():20B-26B. PubMed ID: 8616725
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Controlled randomized clinical trials].
    Jaillon P
    Bull Acad Natl Med; 2007; 191(4-5):739-56; discussion 756-8. PubMed ID: 18225427
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.